Cyclophosphamide-Associated Acneiform Drug Eruption in a Patient with Multiple Myeloma

    Ivanka Kovalyshyn, Amin D. Bijal, Mario E. Lacouture, Isaac Brownell
    Image of study
    TLDR A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.
    A 67-year-old male patient with multiple myeloma developed a pustular eruption on his scalp, face, neck, upper chest, and back after starting treatment with cyclophosphamide and dexamethasone. The eruption, which began three days after the initiation of cyclophosphamide, was characterized by erythematous pustules and was most prominent on the face. Histologic examination revealed a neutrophil-rich infiltrate around hair follicles, consistent with a neutrophilic drug reaction. Other potential diagnoses such as steroid acne and pityrosporum folliculitis were ruled out due to the distribution of the lesions and absence of yeast overgrowth. Upon discontinuation of cyclophosphamide and initiation of topical fluocinonide emollient cream, the eruption receded within one day and completely resolved in six weeks. The patient's medical oncologist replaced cyclophosphamide with oral lenalidomide while continuing oral dexamethasone, and no further skin complaints were reported. This case suggests that cyclophosphamide should be considered in the differential diagnosis for patients presenting with acneiform eruptions.
    Discuss this study in the Community →

    Related Community Posts Join

    0 / 0 results
    — no results

    Similar Research

    5 / 791 results
      Medications

      research Medications

      January 2016 in “Springer eBooks”
      Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.
      Reporting on Adverse Clinical Events

      research Reporting on Adverse Clinical Events

      March 2021 in “Clin-Alert”
      The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.